About ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
During the past decade, ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C"
#1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
According to Clinical.Site data, the most researched conditions in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C" are
"Chronic Lymphocytic Leukemia" (2 trials), "Small Lymphocytic Lymphoma" (2 trials), "Breast Cancer" (1 trials), "Colon Cancer" (1 trials) and "Medullary Thyroid Cancer" (1 trials). Many other conditions were trialed in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C" in a lesser frequency.
Clinical Trials Intervention Types at ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
Most popular intervention types in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Bendamustine" (2 trials), "Rituximab" (2 trials), "Idelalisib" (1 trials), "LOXO-305" (1 trials) and "Pirtobrutinib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
The vast majority of trials in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C" are
3 trials for "All" genders.
Clinical Trials Status at ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C
Currently, there are NaN active trials in "ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ASST Grande Ospedale Metropolitano Niguarda Comitato Etico Milano Area C, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".